StonvexLoading…
StonvexStonvexStonvexCore line items from BRLT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $99.50M | $437.48M | $313.07M | $202.82M |
Operating Income | $-8.88M | $-5.38M | $-5.36M | $-4.74M |
Net Income | $-1.51M | $-3.63M | $-739.00K | $-632.00K |
EPS (Diluted) | $-0.10 | $-0.25 | $-0.05 | $-0.04 |
Total Assets | $183.43M | $200.90M | $202.97M | $260.88M |
Total Liabilities | $112.08M | $121.27M | $123.91M | $158.19M |
Cash & Equivalents | $58.56M | $79.09M | $73.43M | $133.62M |
Free Cash Flow OCF − CapEx | $-19.35M | $5.75M | $58.00K | $61.00K |
Shares Outstanding | 15.81M | 14.75M | 14.56M | 14.33M |